PACE modifications have enjoyed a resurgence in interest as applied to the field of CRISPR gene editing. In an initial publication, it was shown that single guide RNAs (sgRNA) provided significantly higher activity in cells when 2‘-O-methylthiophosphonoacetates were incorporated on the ends of the guide RNA to protect against cellular nucleases.1 In subsequent studies, 2’-OMe PACE modified sgRNAs were also shown to significantly increase on-target specificity of the CRISPR-Cas9 DNA cleavage in eukaryotic cells. In a recent paper, the incorporation of 2’-OMe PACE modified nucleotides in the 20-nucleotide guide region of the sgRNA was shown to decrease off-target cutting by over an order of magnitude while in most cases increasing the overall on-target efficiency as compared to unmodified single guide RNA.2As an optimal cycle, we recommend using DCI as an activator (30-3150-XX) and a 15 minute coupling time. Following coupling, cap using Unicap with a regular coupling time and then oxidize using 0.5 M CSO for 3 minutes. Alternatively, a 33 minute coupling time using 0.45 M tetrazole, oxidation using low-water iodine (40-4032-XX) followed by capping with 6.5% DMAP as Cap B will give acceptable results. For deprotection, pre-treat the synthesis column with 1.5% DBU in anhydrous acetonitrile for 60 minutes at room temperature to remove 1,1-dimethyl-2-cyanoethyl protecting groups. Rinse the column with ACN, dry under argon and complete deprotection with 40% Methylamine for 2 hours at room temperature.
Specifications | |
---|---|
Diluent | Anhydrous Acetonitrile |
Storage | Freezer storage, -10 to -30�C, dry |
Stability | 2-3 days |
The table below show pack size data and, for solutions, dilution and approximate coupling based on normal priming procedures.
Catalog # | Pack Size | Grams/Pack | 0.1M Dil. (mL) | Approximate Number of Additions | |||||
---|---|---|---|---|---|---|---|---|---|
LV40 | LV200 | 40nm | 0.2μm | 1μm | 10μm | ||||
10-3153-02 | 0.25 g | 0.25 | 3.01 | 87 | 52.2 | 32.63 | 23.73 | 17.4 | 4.35 |
10-3153-05 | 0.5 g | 0.5 | 6.02 | 187.33 | 112.4 | 70.25 | 51.09 | 37.47 | 9.37 |
10-3153-10 | 1.0 g | 1 | 12.03 | 387.67 | 232.6 | 145.38 | 105.73 | 77.53 | 19.38 |
Catalog # | Pack Size | Grams/Pack | Dilution (mL) | Approximate Number of Additions | ||||
---|---|---|---|---|---|---|---|---|
Molarity | 50nm | 0.2μm | 1μm | 15μm | ||||
10-3153-02 | 0.25 g | 0.25 | 4.49 | 0.07 | 83.4 | 52.13 | 37.91 | 5.21 |
10-3153-05 | 0.5 g | 0.5 | 8.98 | 0.07 | 173.2 | 108.25 | 78.73 | 10.83 |
10-3153-10 | 1.0 g | 1 | 17.96 | 0.07 | 352.8 | 220.5 | 160.36 | 22.05 |
1. A. Hendel, et al., Nat Biotechnol, 2015, 33, 985-989.2. D.E. Ryan, et al., Nucleic Acids Res, 2018, 46, 792-803.
Glen Research提供了多种荧光团和荧光猝灭剂,可以在寡核苷酸合成过程中的5'-或3'-末端或序列内添加。所得的荧光寡核苷酸探针通常用于多种应用,例如遗传和基因组分析以及法医分析。荧光寡核苷酸探针的常见应用是FRET和分子信标探针。
生产和包装用于荧光探针设计的Glen Research产品,以确保在商业合成仪上获得最高性能。每批都附有分析报告和HPLC迹线,显示了我们质量控制测试的结果。Glen Research单体包装在行业标准的小瓶中,并经过专门清洁以消除微粒污染。